This is a national surveillance report using U.S. birth certificate data from 2016–2024, published by the CDC’s National Vital Statistics System. It includes essentially all live births in the U.S. over this period (millions of pregnancies). Researchers used standardized checkboxes on birth records to identify gestational hypertension and related pregnancy complications. The main outcome was how often gestational hypertension occurred and how rates changed over time by age, race/ethnicity, and geography.
Rates of gestational hypertension increased steadily from 2016 through 2024, after adjusting for changes in maternal age and other basic factors. The rise occurred across most demographic groups, though absolute rates and the size of the increase differed by race/ethnicity and state. Gestational hypertension was more common among older mothers and those with certain risk profiles noted on the birth certificate (such as higher pre-pregnancy BMI). The report focuses on describing patterns over time, not on proving exact causes, but the trends are statistically robust due to the very large national dataset.
The study relies on birth certificate checkboxes, which can miss or misclassify some cases and do not capture detailed clinical data (exact blood pressure values, timing, or treatment). It is observational and descriptive, so it cannot prove why rates increased or which specific factors caused the changes. Some important confounders—such as diet, exercise, detailed medical histories, or socioeconomic stress—are not fully measured. The findings apply to U.S. births and may not generalize to other health systems; they also cannot predict an individual person’s risk and should be interpreted alongside clinical evaluation.
The consistent year‑over‑year rise in gestational hypertension across a massive national dataset suggests a true worsening of maternal cardiometabolic health rather than random fluctuation. While birth certificate data have known accuracy limits, the trend is strong and aligns with broader increases in obesity, metabolic syndrome, and chronic hypertension in reproductive‑age women. From a restorative perspective, this underscores the need to identify and address blood pressure, inflammation, insulin resistance, sleep, and stress well before conception. It supports existing literature that hypertensive disorders of pregnancy are increasing and predicts future cardiovascular risk, reinforcing pregnancy as a key window into long‑term maternal health.
People planning pregnancy can ask to have blood pressure, weight, fasting glucose/insulin, lipids, and kidney function checked before conceiving, not only once pregnant. Tracking menstrual cycles and ovulation can help time preconception labs and lifestyle changes (nutrition, movement, sleep, stress reduction) to support healthier vascular and metabolic function. During pregnancy, regular prenatal visits and blood pressure checks are critical; report headaches, vision changes, sudden swelling, or rapid weight gain promptly. A restorative team can help explore root contributors such as insulin resistance, inflammation, autoimmune issues, and sleep apnea, and support gradual improvements before and between pregnancies.
This report shows that more pregnant people in the U.S. are developing gestational hypertension now than they were in 2016. Gestational hypertension is high blood pressure that begins after you become pregnant and can affect both your health and your baby’s health if it worsens. The rise suggests that underlying health issues—like weight, blood sugar, blood pressure, inflammation, and stress—before pregnancy may be getting more common. For someone on a fertility journey, this means it is especially important to look at root causes early: get your blood pressure, metabolism, and overall health checked before and during pregnancy so you and your care team can reduce risks as much as possible.
The national NVSS trends highlight gestational hypertension as a growing burden, reinforcing the need for preconception cardiometabolic screening as a standard component of restorative fertility care. Consider early evaluation of BP trajectory, BMI/waist circumference, fasting glucose, insulin/HOMA‑IR, lipid profile, hs‑CRP, kidney function, thyroid function, and sleep apnea risk in women seeking fertility support. Integrate cycle charting to time evaluations (e.g., luteal‑phase markers of inflammation or fluid shifts) and to monitor how lifestyle or medical interventions affect symptoms like headaches, edema, or blood pressure fluctuations over the cycle. For at‑risk patients, tighter surveillance during pregnancy (home BP monitoring, earlier referral for concerning trends, and postpartum follow‑up of hypertensive disorders) is key, given the link between gestational hypertension and future CVD; this aligns with viewing pregnancy as a stress test uncovering underlying vascular and metabolic vulnerability.
Educational insights, not a diagnosis or individualized treatment advice. Discuss findings with your own clinician. Visit Reproductive Health Insights to explore fertility resources.